US Drug Registration is a mandatory regulatory requirement for any company involved in manufacturing, processing, repacking, relabeling, or distributing drugs intended for the United States market. This process is governed by the U.S. Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Both US-based and foreign pharmaceutical companies must comply with FDA drug registration and listing rules before their products can legally enter or be sold in the United States.
What Is US Drug Registration?
US Drug Registration refers to two core FDA obligations:
- Drug Establishment Registration
- FDA Drug Listing
Establishment registration identifies the physical location where drugs are manufactured or processed, while drug listing provides detailed information about each drug product marketed in the US.
It is important to note that FDA registration does not mean FDA approval. Registration is a regulatory notification requirement, whereas approval applies only to certain drug categories through separate FDA review processes.
Who Needs FDA Drug Registration?
FDA drug registration applies to a wide range of entities, including:
- Prescription drug manufacturers
- Over-the-counter (OTC) drug manufacturers
- Contract manufacturing organizations (CMOs)
- Repackers and relabelers
- Foreign drug manufacturers exporting to the US
Foreign establishments must also appoint a US Agent, who serves as the FDA’s official point of contact for inspections, compliance communication, and regulatory correspondence.
FDA Drug Establishment Registration
Each drug manufacturing facility must be registered separately with the FDA. Registration is mandatory and annual.
Key Registration Facts
- Registration period: October 1 to December 31
- Applies to both domestic and foreign facilities
- Must be renewed every year
- Required prior to FDA inspection and product importation
Failure to maintain an active registration can result in shipment refusal, import alerts, or regulatory enforcement.
FDA Drug Listing Explained
After establishment registration, companies must complete FDA drug listing for every drug product marketed in the United States.
Drug listing includes information such as:
- Drug name (brand and generic)
- Dosage form and strength
- Route of administration
- Labeler details
- National Drug Code (NDC) data
- Product labeling information
All drug listings are submitted electronically using the FDA’s Structured Product Labeling (SPL) format.
National Drug Code (NDC) and Its Importance
The National Drug Code (NDC) is a unique identifier assigned to drug products listed with the FDA. Although the FDA does not “approve” NDC numbers, accurate NDC configuration is essential for:
- Commercial distribution
- Pharmacy and hospital systems
- Insurance reimbursement
- Import and export documentation
Errors in NDC structure or product data often lead to listing rejections or compliance issues.
Common Challenges in US Drug Registration
Many companies face delays due to technical or regulatory errors, including:
- Incorrect SPL file formatting
- Mismatch between labeling and listing data
- Missing or incorrect US Agent information
- Failure to renew annual registration
- Confusion between FDA registration and drug approval
These issues can disrupt market entry timelines and trigger FDA scrutiny.
FDA Inspections and Compliance
Once registered, drug establishments become subject to FDA inspections. These inspections assess compliance with:
- Current Good Manufacturing Practices (cGMP)
- Labeling regulations
- Quality systems
- Data integrity standards
Accurate and up-to-date registration and listing data help reduce inspection risks and compliance concerns.
Why Work With an FDA Drug Registration Consultant?
US Drug Registration requires regulatory expertise, technical submission capability, and ongoing compliance management. Mistakes can result in delays, import holds, or enforcement actions.
XPRO America, a US FDA Consultancy, provides comprehensive FDA drug registration and listing services for both US and international companies. Their regulatory specialists manage the complete process, including establishment registration, drug listing, SPL submissions, NDC setup, US Agent support, and annual renewals.
Organizations seeking structured, compliant, and time-efficient FDA registration support can reach the consulting team at support@xproamerica.com to discuss their specific regulatory requirements.
Conclusion
US Drug Registration is a foundational requirement for accessing the American pharmaceutical market. While the process may appear administrative, it demands precision, regulatory knowledge, and continuous maintenance.
By ensuring accurate FDA establishment registration and drug listing—and partnering with an experienced US FDA consultancy—companies can reduce compliance risks and focus on successful market entry and long-term growth.
Leave a Reply